Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-06-030377
Filing Date
2006-07-31
Accepted
2006-07-31 17:10:05
Documents
5
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 v048558_10k-a.txt 10-K/A 331516
2 v048558_ex31-1.txt EX-31.1 4952
3 v048558_ex31-2.txt EX-31.2 5320
4 v048558_ex32-1.txt EX-32.1 1500
5 v048558_ex32-2.txt EX-32.2 2182
  Complete submission text file 0001144204-06-030377.txt   346999
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-13441 | Film No.: 06991768
SIC: 2836 Biological Products, (No Diagnostic Substances)